Clonidine, but not guanfacine, impairs choice reaction time performance in young healthy volunteers

Neuropsychopharmacology

Volumn 21, Issue 4, 1999, Pages 495-502

  Jakala P ^a   Riekkinen, M ^a   Sirvio J ^a   Koivisto, E ^a   Riekkinen Jr , P ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Adrenergic 2 Agonist pharmacology; Attention drug effects; Clonidine pharmacology; Guanfacine pharmacology; Noradrenaline pharmacology; 2 receptors, Adrenergic, 2 drug effects

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR; ALPHA 2C ADRENERGIC RECEPTOR; CLONIDINE; GUANFACINE; PLACEBO;

ARTICLE; ATTENTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPONSE TIME; SEDATION; WORKING MEMORY;

EID: 0345035479     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(99)00048-2     Document Type: Article

References (51)

1. Aghajanian G.K., Cederbaum J.M., Wang R.Y. Evidence for norepinephrine-mediated collateral inhibition of locus coeruleus neurons. Brain Res. 136:1977;570-577.
2. Aghajanian G.K., VanderMaelen C.P. Alpha 2-adrenoceptor mediated hyperpolarization of locus coeruleus neurons. Intracellular studies in vivo Science. 215:1982;1394-1396.
3. Aoki C., Go C.-G., Venkatesan C., Kurose H. Perikaryal and synaptic localization of α-2A-adrenergic receptor-like immunoreactivity. Brain Res. 650:1994;181-204.
4. 2-noradrenergic mechanisms to prefrontal cortical cognitive function. Arch Gen Psychiatry. 53:1996;448-455.
5. Arnsten A.F.T., Steere J.C., Jetsch D.J., Li B.M. Noradrenergic influences on prefrontal cortical cognitive function. Opposing actions at postjunctional alpha1 versus alpha2-adrenergic receptors Adv Pharmacol. 42:1998;764-767.
6. Aston-Jones G., Shipley M.T., Ennis M., Williams J.T., Pieribone V.A. Restricted afferent control of locus coeruleus neurones revealed by anatomical, physiological, and pharmacological studies. Heal D.J., Marsden C.A. The Pharmacology of Noradrenaline in the Central Nervous System. 1990;187-247 Oxford University Press, New York.
7. Berridge C.W., Foote S.L. Effects of locus coeruleus activation on electroencephalographic activity in neocortex and hippocampus. J Neurosci. 11:1991;3135-3145.
8. Björklund M.G., Riekkinen M., Puoliväli J., Santtila P., Sirviö J., Scheinin M., Haapalinna A., Riekkinen P. Jr. Alpha2c-adrenoceptor overexpressing mice are impaired in executing nonspatial and spatial escape strategies. Mol Pharmacol. 54:1998;569-575.
9. Björklund M.G., Sirviö J., Sallinen J., Scheinin M., Kobilka B., Riekkinen P. Jr. Alpha2c-adrenoceptor overexpression disrupts execution of spatial and non-spatial search patterns. Neuroscience. 4:1999;1187-1198.
10. Borkowski J.G., Benton A.L., Spreen O. Word fluency and brain damage. Neuropsychologia. 5:1967;135-140.
11. Carli M., Robbins T.W., Evenden J.L., Everitt B.J. Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats. Implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal Behav Brain Res. 9:1983;361-380.
12. Cederbaum J.M., Aghajanian G.K. Noradrenergic neurons of the locus coeruleus. Inhibition by epinephrine and activation by the alpha-antagonist piperoxane Brain Res. 112:1976;413-419.
13. Clark C.R., Geffen G.M., Geffen L.B. Catecholamines and the covert orientation of attention in humans. Neuropsychologia. 27:1989;131-139.
14. Cole B.J., Robbins T.W. Amphetamine impairs the discriminative performance of rats with dorsal noradrenergic bundle lesions on a 5-choice serial reaction time task. New evidence for central dopaminergic-noradrenergic interactions Psychopharmacology. 92:1987;458-466.
15. Cole B.J., Robbins T.W. Forebrain norepinephrine. Role in controlled information processing in the rat Neuropsychopharmacology. 7:1992;129-142.
16. Coull J.T., Middleton H.C., Robbins T.W., Sahakian B.J. Clonidine and diazepam have differential effects on tests of attention and learning. Psychopharmacology. 120:1995;322-332. a.
17. Coull J.T., Sahakian B.J., Middleton H.C., Young A.H., Park S.B., McShane R.H., Cowen P.J., Robbins T.W. Differential effects of clonidine, haloperidol, diazepam and tryptophan depletion on focused attention and attentional search. Psychopharmacology. 121:1995;222-230. b.
18. Coull J.T., Frith C.T., Dolan R.J., Frackowiak R.S.J., Grasby P.M. The neural correlates of the noradrenergic modulation of human attention, arousal and learning. Eur J Neurosci. 9:1997;589-598.
19. Downes J.J., Roberts A.C., Sahakian B.J., Evenden J.L., Morris R.G., Robbins T.W. Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease. evidence for a specific attentional dysfunction Neuropsychologia. 27:1989;1329-1343.
20. Engberg G., Eriksson E. Effects of alpha 2-adrenoceptor agonists on locus coeruleus firing rate and brain noradrenaline turnover in N-ethoxycarbonyl.2.ethoxy-1,2-dihydroquinoline (EEDQ)-treated rats. Naunyn-Schmiedebergs-Arch-Pharmacol. 343:1991;472-477.
21. Foote S.L., Morrison J.H. Extrathalamic modulation of cortical function. Ann Rev Neurosci. 10:1987;67-95.
22. Frith C.D., Dowdy J., Ferrier I.N., Crow T.J. Selective impairment of paired associative learning after administration of a centrally-acting adrenergic agonist (clonidine). Psychopharmacology Berl. 87:1985;490-493.
23. Harley C.W. A role for norepinephrine in arousal, emotion, and learning? Limbic modulation by norepinephrine and the Key hypothesis. Prog Neuro-Psychopharmacol Biol Psychiatry. 11:1987;419-458.
24. Hills M., Armitage H. The two-period cross-over clinical trial. Br J Pharmacol. 8:1979;7-20.
25. 2-adrenoceptor subtypes to regulation of cAMP production in transfected S115 cells. Eur J Pharmacol Mol Pharmacol Sect. 266:1994;165-174.
26. 2-adrenoceptor antagonist, on the performance of rats in a five-choice serial reaction time task. Pharmacol Biochem Behav. 42:1992;903-907.
27. Jäkälä P., Sirviö J., Koivisto E., Kejonen K., Vanhanen M., Riekkinen P. Jr. Guanfacine, but not clonidine, improves planning and working memory in man. Neuropsychopharmacology. 20:1999;460-470.
28. Kobilka B.K., Matsui H., Kobilka T.S., Yang-Feng T.L., Francke U., Caron M.G., Lefkowitz R.J., Regan J.W. Cloning, sequencing, and expression of the gene encoding for the human platelet α-2-adrenergic receptor. Science. 238:1987;650-656.
29. Lakhlani P.P., MacMillan L.B., Guo T.Z., McCool B.A., Lovinger D.M., Maze M., Limbird L. Substitution of a mutant alpha2a-adrenergic receptor via 'hit and run' gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo. Proc Natl Acad Sci USA. 94:1997;9950-9955.
30. Lee A., Wissekerke A.E., Rosin D.L., Lynch K.R. Localization of alpha2c-adrenergic receptor immunoreactivity in catecholiaminergic neurons in the rat central nervous system. Neuroscience. 84:1998;1085-1096.
31. Langer S.Z. Presynaptic regulation of monoaminergic neurons. Meltzer H.Y. Psychopharmacology, The Third Generation of Progress. 1987;151-158 Raven Press, New York.
32. Lomasney J.W., Lorenz W., Allen L.F., King K., Regan J.W., Yang-Feng T.L., Caron M., Lefkowitz R.J. Expansion of the α-2-adrenergic family. cloning and characterization of a human α-2-adrenergic receptor subtype, the gene for which is located on chromosome 2 Proc Natl Acad Sci USA. 87:1990;5094-5098.
33. 2-adrenoceptor subtype function. Trends Pharmacol Sci. 18:1997;211-219.
34. 2a-adrenergic receptor subtype. Science. 273:1996;801-803.
35. McCormick D.A. Cholinergic and noradrenergic modulation of thalamocortical processing. Trends Neurosci. 12:1989;215-221.
36. Quintin L., Buda M., Hilaire G., Bardelay C., Ghigone M., Pujol J.F. Catecholiamine metabolism in the rat locus coeruleus as studied by in vivo differential pulse voltametry. III Evidence for the existence of an alpha 2-adrenergic tonic inhibition in behaving rats. Brain Res. 375:1986;235-245.
37. Regan J.W., Kobilka T.S., Yang-Feng T.L., Caron M.G., Lefkowitz R.J., Kobilka B.K. Cloning and expression of a human kidney cDNA for an α-2-adrenergic receptor subtype. Proc Natl Acad Sci USA. 85:1988;6301-6305.
38. 2-adrenoceptor stimulation on neocortical EEG activity in control and 6-hydroxydopamine dorsal noradrenergic bundle-lesioned rats. Eur J Pharmacol. 238:1993;263-272.
39. Riekkinen M., Kejonen K., Jäkälä P., Soininen H., Riekkinen P. Jr. Reduction of noradrenaline impairs attention and dopamine depletion slows responses in Parkinson's disease. Eur J Neurosci. 10:1998;1429-1435.
40. Robbins T.W., Everitt B.J. Arousal systems and attention. Gazzaniga M.S. The Cognitive Neurosciences. 1994;703-720 MIT Press, Cambridge, MA.
41. Sahakian B.J., Owen A.M. Computerized assessment in neuropsychiatry using CANTAB. Discussion paper J Royal Soc Med. 85:1992;399-402.
42. Sallinen J., Link R.E., Haapalinna A., Viitamaa T., Kulatunga M., Sjöholm B., MacDonald E., Pelto-Huikko M., Leino T., Barsh G.S., Kobilka B., Scheinin M. Genetic alteration of alpha2c-adrenoceptor expression in mice. Influence on locomotor, hypothermic, and neurochemical effects of dexmedetomidine, a subtype non-selective alpha2-adrenoceptor agonist Mol Pharmacol. 51:1997;36-46.
43. Scheinin M., Lomasney J.W., Hayden-Hixson D.M., Schambra U.B., Caron M.G., Lefkowitz R.J., Fremeau R.T. Distribution of α-2-adrenergic receptor subtype gene expression in rat brain. Mol Brain Res. 21:1994;133-149.
44. 2-antagonist, on the performance of rats in a five-choice serial reaction time task. Pharmacol Biochem Behav. 45:1993;123-129.
45. 2 adrenergic agents on the performance of rats in a 5-choice serial reaction time task. Brain Res Bull. 35:1994;451-455.
46. 2-adrenoceptor antagonist idazoxan on mood, memory and attention in normal volunteers. J Psychopharmacol. 6:1992;376-381.
47. Smith A., Nutt D. Noradrenaline and attention lapses. Nature. 380:1996;291.
48. 2-adrenoceptor agonist, on spatial working memory in mice. Eur J Neurosci.
49. Uhlen S., Wikberg J.E.S. Delineation of rat kidney α-2A and α-2B-adrenoceptors with [3H]RX821002 radiologand binding. Computer modeling reveals that guanfacine is an α-2A-selective compound Eur J Pharmacol. 202:1991;235-243.
50. U'Prichard D.C., Bechtel W.D., Rouot B.M., Snyder S.H. Multiple apparent α-noradrenergic receptor binding sites in rat brain. Mol Pharmacol. 16:1979;47-60.
51. Wechsler D. Wechsler Adult Intelligence Scale - Revised. Manual. 1992;The Psychological Corporation, New York, NY.